174.65
+1.45
+(0.84%)
At close: April 17 at 7:35:12 PM GMT+2
Key Executives
Key Executives Information Not Available
Genmab A/S
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Genmab A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 8, 2025 at 3:00 PM UTC
Genmab A/S Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
ZVA.F Cellectis S.A.
1.3260
+0.61%
BV3A.F Bavarian Nordic A/S
6.45
-3.01%
1AEA.SG argenx SE
510.00
+0.99%
49BA.SG BeiGene Ltd
202.00
+1.51%
4R0.F Oxford Nanopore Technologies plc
1.3020
-3.12%
22Z.F Zealand Pharma A/S
56.76
-5.40%
IMTXW Immatics N.V.
0.0134
+7.20%
AYJ.F Valneva SE
3.0440
+0.46%
BCAX Bicara Therapeutics Inc.
12.16
+3.40%
RLMD Relmada Therapeutics, Inc.
0.2898
-0.75%